DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
5 hedge funds and large institutions have $8.22M invested in DermTech, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
3% more capital invested
Capital invested by funds: $7.95M → $8.22M (+$268K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSU
Mizuho Securities USA
New York
|
+$215K |
| 2 |
CI
Cowen Inc
New York
|
+$126K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
+$92.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
-$155K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$77.1K |
DMTK Hedge Fund Activity: Q2 2019 in Review
5 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q2 2019, worth a combined $8.22M — up 3.4% from $7.95M a quarter earlier.
Fund positioning in DMTK was balanced in Q2 2019: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Mizuho Securities USA, opening a new position worth an estimated $215K. The largest seller was Kepos Capital, exiting entirely with an estimated $155K sold.
- 5 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $8.22M of DermTech, Inc. Common Stock stock for Q2 2019, up 3.4% quarter-over-quarter.
- 2 funds opened new DermTech, Inc. Common Stock positions in Q2 2019 and 2 closed out, a net change of 0 holders.
- The largest DermTech, Inc. Common Stock buyer in Q2 2019 was Mizuho Securities USA, an estimated $215K added.
- The largest DermTech, Inc. Common Stock seller in Q2 2019 was Kepos Capital, an estimated $155K sold.
Based on aggregated 13F filings for Q2 2019.